Peer-reviewedCC BY-NC-NDJournal of thoracic disease
CDK4/6 inhibitor-related interstitial lung disease in breast cancer: a single-center case series and literature-based patient-level review
Related
- A Rare Endobronchial Lipoma of the Right Middle Lobe Causing Middle Lobe Syndrome and Recurrent Post‐Obstructive Infection in a Patient With Interstitial Lung Disease, Managed by Lung‐Sparing Bronchoscopy
- Hybrid surgical thromboembolectomy and crossover endovascular revascularization for acute lower-limb ischemia in a patient with active ovarian cancer receiving a PARP inhibitor (fuzuloparib): a case report and literature review
- Equivocal and definite interstitial lung abnormalities as risk factors for trastuzumab deruxtecan-related interstitial lung disease in breast cancer
- Anti-GBM disease shortly after clinically presumed ANCA-associated vasculitis in an 85-year-old patient: a case report and literature review
- Health-Related Quality of Life in Patients With Fibrosing Interstitial Lung Diseases: A Study Using the King’s Brief Interstitial Lung Disease (K-BILD) Questionnaire
BibTeX
@article{anon2026cdk46,
title = {{CDK4/6 inhibitor-related interstitial lung disease in breast cancer: a single-center case series and literature-based patient-level review}},
journal = {Journal of thoracic disease},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13655905},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - CDK4/6 inhibitor-related interstitial lung disease in breast cancer: a single-center case series and literature-based patient-level review
PY - 2026
DA - 2026/08/17
JO - Journal of thoracic disease
UR - https://europepmc.org/article/PMC/PMC13655905
SN - 2072-1439
SN - 2077-6624
ER -